Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Millennium Hotel & Convention Centre Kuwait

21 nov 2017 7:30 a.m. - 22 nov 2017 5:30 p.m.

4th Ring Road, Salmiya, Abou Thar Al Ghafari St Safat , 13154 Kuwait, Kuwait City, 29370, Kuwait

DIA Middle East Regulatory Conference

Session 1, Part 2: Panel Discussion - Stakeholders Experience Regarding Reliance Procedures

Session Chair(s)

Paul  Dearden

Paul Dearden

Senior Director, Global Regulatory Policy

Biogen, United Kingdom

Panel Discussion: Stakeholders Experience Regarding Reliance Procedures

Speaker(s)

Bandar  Al Hammad, MPharm

Bandar Al Hammad, MPharm

Saudi Food and Drug Authority (SFDA), Saudi Arabia

Chief Pharmacist & Director of Veterinary Preparations Department

Ghadeer  Al-Sheikh Salem

Ghadeer Al-Sheikh Salem

Jordan Food and Drug Administration, Jordan

Head, Originator and Biological Drugs Division, Registration Department

Inas  Chehimi

Inas Chehimi

Novartis Pharma Services AG, United Arab Emirates

Head Regulatory Affairs - Middle East & North Africa

Hajed M.H Hashan

Hajed M.H Hashan

Gulf Health Council, Saudi Arabia

Deputy of General Director

Stuart Russel Walker, PhD

Stuart Russel Walker, PhD

Centre for Innovation In Regulatory Science (CIRS), United Kingdom

Professor and Consultant

Rasha  Ziada

Rasha Ziada

EDA, Egypt

EDA Chairman Assistant for Technical Development & Capacity Building Affairs

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.